Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process

Regulators from the jurisdictions represented in this WG are collaborating to facilitate regulatory harmonization and foster international alignment of pediatric CTs. By interacting with their respective regulatory bodies and developing expertise in their jurisdiction's regulatory requirements, national pediatric networks can support both academic and industry sponsors in navigating the regulatory process for CTs.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2025-04-15
DOI
https://doi.org/10.3389/fmed.2025.1542408
Citations
1
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
3.49

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process

Pamela Dicks, Hidefumi Nakamura, Donna L. Snyder, Dionna Green et al.
1 citations
Frontiers in Medicine
Pharmaceutical studies and practices
3.49
article

Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process

Pamela Dicks, Hidefumi Nakamura, Donna L. Snyder, Dionna Green, Collin A. Hovinga, Gunter F. Egger, Andrew Davidson, Thierry Lacaze‐Masmonteil, Alysha Croker, Faisal Ali, Kanecia Obie Zimmerman, Saul N. Faust, I Villa, Shaun Ramroop, Pirkko Lepola, Michiyo Sakiyama, Sato Junko, Laura Pioppo, M. Turner, Sarah Zaidi, Ágnes Klein, Breanne Stewart, Albert J. Allen, Robyn Langham
article en
1 citations

Abstract

Regulators from the jurisdictions represented in this WG are collaborating to facilitate regulatory harmonization and foster international alignment of pediatric CTs. By interacting with their respective regulatory bodies and developing expertise in their jurisdiction's regulatory requirements, national pediatric networks can support both academic and industry sponsors in navigating the regulatory process for CTs.

Frontiers in MedicineVol. 12
Health Canada (CA), European Medicines Agency (NL), United States Food and Drug Administration (US), University of Helsinki (FI), University of Liverpool (GB), Duke University (US), Helsinki University Hospital (FI), Australian Government (AU), Critical Path Institute (US), University Hospital Southampton NHS Foundation Trust (GB), Department of Health and Aged Care (AU), Clinical Research Institute (US), Royal Aberdeen Children's Hospital (GB), NIHR Southampton Biomedical Research Centre (GB), National Center For Child Health and Development (JP), Go4children (NL), Murdoch Children's Research Institute (AU), University of Southampton (GB), Pharmaceuticals and Medical Devices Agency (JP)
U.S. Department of Health and Human Services, Genome Canada, Canadian Institutes of Health Research
Partnerships for the goals
Openalex Percentile: Top 11%
Pharmaceutical studies and practices
3.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.